BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8659500)

  • 1. Alterations in soluble intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in hemodialysis patients.
    Rabb H; Calderon E; Bittle PA; Ramirez G
    Am J Kidney Dis; 1996 Feb; 27(2):239-43. PubMed ID: 8659500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemodialysis procedure does not affect the levels of sICAM-1 and sVCAM-1 in patients with end stage renal disease.
    Liakopoulos V; Eleftheriadis T; Kyropoulos T; Voliotis G; Potamianos S; Zengos N; Stefanidis I; Heintz B
    Ren Fail; 2005; 27(3):315-21. PubMed ID: 15957549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble adhesion molecules in children and young adults on chronic hemodialysis.
    Musiał K; Zwolińska D; Polak-Jonkisz D; Berny U; Szprynger K; Szczepańska M
    Pediatr Nephrol; 2004 Mar; 19(3):332-6. PubMed ID: 14745633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is dialysis membrane type responsible for increased circulating adhesion molecules during chronic hemodialysis?
    Mrowka C; Heintz B; Sieberth HG
    Clin Nephrol; 1999 Nov; 52(5):312-21. PubMed ID: 10584995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum levels of soluble adhesion molecules in chronic renal failure and dialysis patients.
    Bonomini M; Reale M; Santarelli P; Stuard S; Settefrati N; Albertazzi A
    Nephron; 1998 Aug; 79(4):399-407. PubMed ID: 9689154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum VCAM-1, ICAM-1, and L-selectin levels in children and young adults with chronic renal failure.
    Musiał K; Zwolińska D; Polak-Jonkisz D; Berny U; Szprynger K; Szczepańska M
    Pediatr Nephrol; 2005 Jan; 20(1):52-5. PubMed ID: 15602666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Higher serum levels of soluble intracellular cell adhesion molecule-1 and soluble vascular cell adhesion molecule predict peripheral artery disease in haemodialysis patients.
    Cheng CH; Chen YS; Shu KH; Chang HR; Chou MC
    Nephrology (Carlton); 2012 Nov; 17(8):718-24. PubMed ID: 22905988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic and prognostic values of adhesion molecules VCAM-1, ICAM-1 and C-reactive protein in Egyptian patients with chronic kidney disease.
    Attalah MF; Adel LA; Fahmy DE
    Egypt J Immunol; 2011; 18(2):59-66. PubMed ID: 23082471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating levels of ICAM-1, VCAM-1, and MCP-1 are increased in haemodialysis patients: association with inflammation, dyslipidaemia, and vascular events.
    Papayianni A; Alexopoulos E; Giamalis P; Gionanlis L; Belechri AM; Koukoudis P; Memmos D
    Nephrol Dial Transplant; 2002 Mar; 17(3):435-41. PubMed ID: 11865089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated serum levels of soluble adhesion molecules predict death in pre-dialysis patients: association with malnutrition, inflammation, and cardiovascular disease.
    Stenvinkel P; Lindholm B; Heimbürger M; Heimbürger O
    Nephrol Dial Transplant; 2000 Oct; 15(10):1624-30. PubMed ID: 11007832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble adhesion molecules in children and young adults with chronic renal failure treated conservatively.
    Musiał K; Zwolińska D; Berny U; Polak-Jonkisz D; Szprynger K; Szczepańska M
    Rocz Akad Med Bialymst; 2004; 49():209-12. PubMed ID: 15631345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-flux and low-flux dialysis membranes and levels of intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in children with chronic kidney failure.
    Sawires HK; Mohamed WA; Schaalan MF
    Iran J Kidney Dis; 2012 Sep; 6(5):366-72. PubMed ID: 22976263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble VCAM-1/soluble ICAM-1 ratio is a promising biomarker for diagnosing endometriosis.
    Kuessel L; Wenzl R; Proestling K; Balendran S; Pateisky P; Yotova ; Yerlikaya G; Streubel B; Husslein H
    Hum Reprod; 2017 Apr; 32(4):770-779. PubMed ID: 28333208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating levels of adhesion molecules in chronic kidney disease correlate with the stage of renal disease and with C-reactive protein.
    Vaccaro F; Mulè G; Cottone S; Soresi M; Giannitrapani L; Vadalà A; Sparacino V; Calabrese S; Picone FP; Montalto G; Cerasola G
    Arch Med Res; 2007 Jul; 38(5):534-8. PubMed ID: 17560459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating soluble adhesion molecules in ANCA-associated vasculitis.
    Ara J; Mirapeix E; Arrizabalaga P; Rodriguez R; Ascaso C; Abellana R; Font J; Darnell A
    Nephrol Dial Transplant; 2001 Feb; 16(2):276-85. PubMed ID: 11158400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood serum levels of vascular cell adhesion molecule (sVCAM-1), intercellular adhesion molecule (sICAM-1) and endothelial leucocyte adhesion molecule-1 (ELAM-1) in diabetic retinopathy.
    Nowak M; Wielkoszyński T; Marek B; Kos-Kudła B; Swietochowska E; Siemińska L; Kajdaniuk D; Głogowska-Szelag J; Nowak K
    Clin Exp Med; 2008 Sep; 8(3):159-64. PubMed ID: 18791689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in serum asymmetric dimethylarginine and endothelial markers levels with varying periods of hemodialysis.
    Yaman A; Karabag F; Demir S; Koken T
    Ther Apher Dial; 2014 Aug; 18(4):361-7. PubMed ID: 25117882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New indices of ischemic heart disease and aging: studies on the serum levels of soluble intercellular adhesion molecule-1 (ICAM-1) and soluble vascular cell adhesion molecule-1 (VCAM-1) in patients with hypercholesterolemia and ischemic heart disease.
    Morisaki N; Saito I; Tamura K; Tashiro J; Masuda M; Kanzaki T; Watanabe S; Masuda Y; Saito Y
    Atherosclerosis; 1997 May; 131(1):43-8. PubMed ID: 9180243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased levels of soluble TNF-alpha receptors and cellular adhesion molecules in patients undergoing bioincompatible hemodialysis.
    Rysz J; Majewska E; Stolarek RA; Banach M; Ciałkowska-Rysz A; Baj Z
    Am J Nephrol; 2006; 26(5):437-44. PubMed ID: 16988495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of rHuEPO therapy initiation on soluble adhesion molecule levels in haemodialysis patients.
    Kahraman S; Yilmaz R; Kirkpantur A; Genctoy G; Arici M; Altun B; Erdem Y; Yasavul U; Turgan C
    Nephrology (Carlton); 2005 Jun; 10(3):264-9. PubMed ID: 15958039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.